Acute lymphoblastic leukemia: Clinical practice guidelines in oncology

Joseph C. Alvarnas; Patrick A. Brown; Patricia Aoun; Karen Kuhn Ballen; Naresh Bellam; William Blum; Michael W. Boyer; Hetty E. Carraway; Peter F. Coccia; Steven E. Coutre; Jennifer Cultrera; Lloyd E. Damon; Daniel J. DeAngelo; Dan Douer; Haydar Frangoul; Olga Frankfurt; Salil Goorha; Michael M. Millenson; Susan O'Brien; Stephen H. Petersdorf; Arati V. Rao; Stephanie Terezakis; Geoffrey Uy; Meir Wetzler; Andrew D. Zelenetz; Maoko Naganuma; Kristina M. Gregory

doi:10.6004/jnccn.2012.0089

Acute lymphoblastic leukemia: Clinical practice guidelines in oncology

Joseph C. Alvarnas, Patrick A. Brown, Patricia Aoun, Karen Kuhn Ballen, Naresh Bellam, William Blum, Michael W. Boyer, Hetty E. Carraway, Peter F. Coccia, Steven E. Coutre, Jennifer Cultrera, Lloyd E. Damon, Daniel J. DeAngelo, Dan Douer, Haydar Frangoul, Olga Frankfurt, Salil Goorha, Michael M. Millenson, Susan O'Brien, Stephen H. PetersdorfArati V. Rao, Stephanie Terezakis, Geoffrey Uy, Meir Wetzler, Andrew D. Zelenetz, Maoko Naganuma, Kristina M. Gregory

Leukemia

Research output: Contribution to journal › Review article › peer-review

51 Scopus citations

Abstract

The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multidisciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL.

Original language	English (US)
Pages (from-to)	858-914
Number of pages	57
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	10
Issue number	7
DOIs	https://doi.org/10.6004/jnccn.2012.0089
State	Published - Jul 1 2012

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2012.0089

Cite this

Alvarnas, J. C., Brown, P. A., Aoun, P., Ballen, K. K., Bellam, N., Blum, W., Boyer, M. W., Carraway, H. E., Coccia, P. F., Coutre, S. E., Cultrera, J., Damon, L. E., DeAngelo, D. J., Douer, D., Frangoul, H., Frankfurt, O., Goorha, S., Millenson, M. M., O'Brien, S., ... Gregory, K. M. (2012). Acute lymphoblastic leukemia: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 10(7), 858-914. https://doi.org/10.6004/jnccn.2012.0089

Alvarnas, JC, Brown, PA, Aoun, P, Ballen, KK, Bellam, N, Blum, W, Boyer, MW, Carraway, HE, Coccia, PF, Coutre, SE, Cultrera, J, Damon, LE, DeAngelo, DJ, Douer, D, Frangoul, H, Frankfurt, O, Goorha, S, Millenson, MM, O'Brien, S, Petersdorf, SH, Rao, AV, Terezakis, S, Uy, G, Wetzler, M, Zelenetz, AD, Naganuma, M & Gregory, KM 2012, 'Acute lymphoblastic leukemia: Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 10, no. 7, pp. 858-914. https://doi.org/10.6004/jnccn.2012.0089

@article{5faa8d96fc6a4005945f8ebe5c24404e,

title = "Acute lymphoblastic leukemia: Clinical practice guidelines in oncology",

abstract = "The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multidisciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL.",

author = "Alvarnas, {Joseph C.} and Brown, {Patrick A.} and Patricia Aoun and Ballen, {Karen Kuhn} and Naresh Bellam and William Blum and Boyer, {Michael W.} and Carraway, {Hetty E.} and Coccia, {Peter F.} and Coutre, {Steven E.} and Jennifer Cultrera and Damon, {Lloyd E.} and DeAngelo, {Daniel J.} and Dan Douer and Haydar Frangoul and Olga Frankfurt and Salil Goorha and Millenson, {Michael M.} and Susan O'Brien and Petersdorf, {Stephen H.} and Rao, {Arati V.} and Stephanie Terezakis and Geoffrey Uy and Meir Wetzler and Zelenetz, {Andrew D.} and Maoko Naganuma and Gregory, {Kristina M.}",

year = "2012",

month = jul,

day = "1",

doi = "10.6004/jnccn.2012.0089",

language = "English (US)",

volume = "10",

pages = "858--914",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "7",

}

TY - JOUR

T1 - Acute lymphoblastic leukemia

T2 - Clinical practice guidelines in oncology

AU - Alvarnas, Joseph C.

AU - Brown, Patrick A.

AU - Aoun, Patricia

AU - Ballen, Karen Kuhn

AU - Bellam, Naresh

AU - Blum, William

AU - Boyer, Michael W.

AU - Carraway, Hetty E.

AU - Coccia, Peter F.

AU - Coutre, Steven E.

AU - Cultrera, Jennifer

AU - Damon, Lloyd E.

AU - DeAngelo, Daniel J.

AU - Douer, Dan

AU - Frangoul, Haydar

AU - Frankfurt, Olga

AU - Goorha, Salil

AU - Millenson, Michael M.

AU - O'Brien, Susan

AU - Petersdorf, Stephen H.

AU - Rao, Arati V.

AU - Terezakis, Stephanie

AU - Uy, Geoffrey

AU - Wetzler, Meir

AU - Zelenetz, Andrew D.

AU - Naganuma, Maoko

AU - Gregory, Kristina M.

PY - 2012/7/1

Y1 - 2012/7/1

N2 - The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multidisciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL.

AB - The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multidisciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL.

UR - http://www.scopus.com/inward/record.url?scp=84865327021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865327021&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2012.0089

DO - 10.6004/jnccn.2012.0089

M3 - Review article

C2 - 22773801

AN - SCOPUS:84865327021

SN - 1540-1405

VL - 10

SP - 858

EP - 914

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 7

ER -

Acute lymphoblastic leukemia: Clinical practice guidelines in oncology

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this